To overcome the scarcity of samples of N-glycosylated tau from brains of AD patients, we generated a novel ex-vivo model, in which human tau (htau) is fused to a signal peptide motif, thereby forcing it through the secretory pathway where it can potentially undergo N-glycosylation. This evidence concerns the gene MAPT and Alzheimer disease.